Colorectal Adenomas Produce Lysozyme

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5165-5171

  Rubio, C A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colon; Lysozyme; Neoplasias

Indexed keywords

LYSOZYME;

ARTICLE; CELLULAR DISTRIBUTION; COLON ADENOMA; COLON MUCOSA; COLORECTAL TUMOR; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM ADENOMA; RECTUM MUCOSA;

ADENOCARCINOMA; ADENOMA; APOPTOSIS; CELL DIVISION; COLONIC POLYPS; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MACROPHAGES; MURAMIDASE;

EID: 0842321837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alexander Fleming. Presentation speech. Nobel Prize Physiology or Medicine 1945. Nobel e-Museum, The Nobel Foundation, 2003.
2. Cunliffe R, Rose F, Keyte J, Abberley L, Chan W and Mahida Y: Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48: 176-185, 2001.
3. Ooi CJ, Lim BL, Cheong WK, Ling AE and Ng HS: Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Ann Acad Med Singapore 29: 704-707, 2000.
4. van der Sluys Veer A, Brouwer J, Biemond I, Bohbouth GE, Verspaget HW and Lamers CB: Fecal lysozyme in assessment of disease activity in inflammatory bowel disease. Dig Dis Sci 43: 590-595, 1998.
5. Caruso RA, La Spada F, Casablanca G and Rigoli L: Lysozyme and mucins in gastric adenomas. J Clin Pathol 42: 827-833, 1989.
6. De Vita O, Bondi A, Euse-Bi V and Bordi C: Simultaneous polypoid tumors of the stomach and duodenum with composite cell population (mucous, argyrophil, and lysozyme-containing cells): a case report. Amer J Gastroenterol 79: 606-610, 1984.
7. Ito H, Hata J, Yokosaki H, Nakatani H, Oda N and Tahara E: Tubular adenoma of the human stomach. An immunohistochemical analysis of gut hormones, serotonin, carcinoembryonic antigen, secretory component, and lysozyme. Cancer 58: 2264-2272, 1986.
8. Ho S, Itzkowitz S, Friera A, Jiang S and Kim Y: Cell lineage markers in premalignant and malignant colonic mucosa. Gastroenterology 97: 392-404, 1989.
9. Geller S and Thung S: Morphologic unity of Paneth cells. Arch Pathol Lab Med 107: 476-479, 1983.
10. Yuen S, Wong M, Chung L, Chan S, Cheung N, Ho J and Leung S: Up-regulation of lysozyme production in colonic adenomas and adenocarcinomas. Histopathology 12: 126-132, 1998.
11. Santini D, Pasquinelly G, Mazzoleni G et al: Lysozyme localization in normal and disease human gastric and colonic mucosa. A correlative histochemical, immunohistochemical and immunoelectron microscopic investigation. APMIS 100: 575-585, 1992.
12. Rubio CA, Porwit-McDonald A, Rodensjö M and Duvander A: A method to quantitate Paneth cell metaplasia of the stomach by image analysis. Anal Quant Cytol Histol 11: 115-118, 1989.
13. Rubio CA, Kanter L, Poppen B and Bry L: Paneth cell-rich flat adenoma of the rectum. Jpn J Cancer Res 87: 96-100, 1996.
14. Nevalainen T, Hapanen T, Rajaala P and Ekfors T: Expression of group II phospholipase A2 in Paneth cells of an adenoma of the rectum. A case report. APMIS 106: 780-784, 1998.
15. Levinson S, Elin R and Yam L: Light chain proteinuria and lysozymuria in a patient with acute monocytic leukaemia. Clin Cheem 48: 1131-1132, 2002.
16. Visozo F, Plaza E, Vazquez J, Serra C, Lamelas M, Gonzalez L, Merino A and Méndez J: Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance. Ann Surg Oncol 8: 667-674, 2001.
17. Rubio CA: Rectal muciphages are rich in lysozyme. A novel source of antimicrobial mucosal defense? Scand J Gastroenterol 37: 743-744, 2002.
18. Rubio CA: A Paneth cell surrogate? Gut 50: 741-742, 2002.
19. Rubio CA: Lysozyme-rich muciphages surrounding colorectal adenomas. Anticancer Res 22: 879-881, 2002.
20. Rubio CA: Nonprotruding colorectal neoplasms: epidemiologic viewpoint. World J Surg 24: 1098-1103, 1998.
21. Rubio CA: Intraepithelial lymphocytes vs. colorectal neoplastic cells: who is winning the apoptotic battle? Apoptosis 2: 489-493, 1997.
22. Rubio CA: Colorectal carcinomas. Possible mechanisms of local tumour progression. Anticancer Res 23: 347-350, 2003.
23. Jass J, Iino H and Ruszkiewicz: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum Gut 47: 43-49, 2000.
24. Liljegren A, Lindblom Annika, Nilsson B, Rotstein S, Rubio CA and Jaramillo E: Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer-a correlation between the two types of colon polyps. Gut 52: 1140-1147, 2003.
25. Davenport A, Hale RJ, Hunt CR, Bigley G and McMahon RT: Expression of Ki-67 and cytokeratin 20 in hyperplastic polyps of the colorectum. J Clin Pathol 56: 200-204, 2003.
26. Rubio CA: A simple method to demonstrate normal and metaplastic Paneth cells in tissue sections. In Vivo 17: 67-72, 2003.